167 related articles for article (PubMed ID: 24727462)
41. Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives.
Zhang Y; Huang YJ; Xiang HM; Wang PY; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2014 May; 78():23-34. PubMed ID: 24675177
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, anticancer activities and molecular modeling studies of novel indole retinoid derivatives.
Gurkan-Alp AS; Mumcuoglu M; Andac CA; Dayanc E; Cetin-Atalay R; Buyukbingol E
Eur J Med Chem; 2012 Dec; 58():346-54. PubMed ID: 23142674
[TBL] [Abstract][Full Text] [Related]
43. Design, Synthesis, and Antitumor Activity of (E,Z)-1-(dihydrobenzofuran-5-yl)-3-phenyl-2-(1,2,4-triazol-1-yl)-2-propen-1-ones.
Li W; Yang ZH; Hu AX; Yan XW; Ding N; Ye J
Chem Biol Drug Des; 2015 Dec; 86(6):1339-50. PubMed ID: 26041467
[TBL] [Abstract][Full Text] [Related]
44. Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.
Manjulatha K; Srinivas S; Mulakayala N; Rambabu D; Prabhakar M; Arunasree KM; Alvala M; Basaveswara Rao MV; Pal M
Bioorg Med Chem Lett; 2012 Oct; 22(19):6160-5. PubMed ID: 22929231
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894
[TBL] [Abstract][Full Text] [Related]
46. Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists.
Ohno M; Tanaka Y; Miyamoto M; Takeda T; Hoshi K; Yamada N; Ohtake A
Bioorg Med Chem; 2006 Mar; 14(6):2005-21. PubMed ID: 16297632
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells.
Lian S; Su H; Zhao BX; Liu WY; Zheng LW; Miao JY
Bioorg Med Chem; 2009 Oct; 17(20):7085-92. PubMed ID: 19773174
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of novel benzo[4,5]thiazolo[1,2-a]pyrimidine-3-carboxylate derivatives and biological evaluation as potential anticancer agents.
Nagarapu L; Vanaparthi S; Bantu R; Ganesh Kumar C
Eur J Med Chem; 2013 Nov; 69():817-22. PubMed ID: 24113366
[TBL] [Abstract][Full Text] [Related]
49. Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.
Hoenke C; Bouyssou T; Tautermann CS; Rudolf K; Schnapp A; Konetzki I
Bioorg Med Chem Lett; 2009 Dec; 19(23):6640-4. PubMed ID: 19875286
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
51. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G
Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292
[TBL] [Abstract][Full Text] [Related]
52. Mixed valence copper(I,II) binuclear complexes with unexpected structure: synthesis, biological properties and anticancer activity.
Majouga AG; Zvereva MI; Rubtsova MP; Skvortsov DA; Mironov AV; Azhibek DM; Krasnovskaya OO; Gerasimov VM; Udina AV; Vorozhtsov NI; Beloglazkina EK; Agron L; Mikhina LV; Tretyakova AV; Zyk NV; Zefirov NS; Kabanov AV; Dontsova OA
J Med Chem; 2014 Jul; 57(14):6252-8. PubMed ID: 24950478
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of the apoptosis inducing and CT DNA interaction properties of a series of 4β-carbamoyl 4'-O-demethylepipodophyllotoxins.
Sang CY; Liu JF; Qin WW; Zhao J; Hui L; Jin YX; Chen SW
Eur J Med Chem; 2013; 70():59-67. PubMed ID: 24140948
[TBL] [Abstract][Full Text] [Related]
54. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
55. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
[TBL] [Abstract][Full Text] [Related]
56. A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents.
Wang X; Pan YM; Huang XC; Mao ZY; Wang HS
Org Biomol Chem; 2014 Apr; 12(13):2028-32. PubMed ID: 24519368
[TBL] [Abstract][Full Text] [Related]
57. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV
Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137
[TBL] [Abstract][Full Text] [Related]
58. Synthesis, X-ray crystallographic analysis, and antitumor activity of 1-acyl-3,6-disubstituted phenyl-1,4-dihydro-1,2,4,5-tetrazines.
Rao GW; Hu WX
Bioorg Med Chem Lett; 2005 Jun; 15(12):3174-6. PubMed ID: 15908202
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of cinnamyl compounds as potent antitumor agents.
Shin DS; Kim J; Han DC; Son KH; Lee CW; Kim HM; Hong SH; Kwon BM
Bioorg Med Chem Lett; 2007 Oct; 17(19):5423-7. PubMed ID: 17683933
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
